-
Je něco špatně v tomto záznamu ?
Robotic Cardiac Surgery in Europe: Status 2020
S. Cerny, W. Oosterlinck, B. Onan, S. Singh, P. Segers, C. Bolcal, C. Alhan, E. Navarra, M. Pettinari, F. Van Praet, H. De Praetere, J. Vojacek, T. Cebotaru, P. Modi, F. Doguet, U. Franke, A. Ouda, L. Melly, G. Malapert, L. Labrousse, M. Gianoli,...
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2014
PubMed Central
od 2014
Europe PubMed Central
od 2014
Open Access Digital Library
od 2014-01-01
Open Access Digital Library
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
35127877
DOI
10.3389/fcvm.2021.827515
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: European surgeons were the first worldwide to use robotic techniques in cardiac surgery and major steps in procedure development were taken in Europe. After a hype in the early 2000s case numbers decreased but due to technological improvements renewed interest can be noted. We assessed the current activities and outcomes in robotically assisted cardiac surgery on the European continent. Methods: Data were collected in an international anonymized registry of 26 European centers with a robotic cardiac surgery program. Results: During a 4-year period (2016-2019), 2,563 procedures were carried out [30.0% female, 58.5 (15.4) years old, EuroSCORE II 1.56 (1.74)], including robotically assisted coronary bypass grafting (n = 1266, 49.4%), robotic mitral or tricuspid valve surgery (n = 945, 36.9%), isolated atrial septal defect closure (n = 225, 8.8%), left atrial myxoma resection (n = 54, 2.1%), and other procedures (n = 73, 2.8%). The number of procedures doubled during the study period (from n = 435 in 2016 to n = 923 in 2019). The mean cardiopulmonary bypass time in pump assisted cases was 148.6 (63.5) min and the myocardial ischemic time was 88.7 (46.1) min. Conversion to larger thoracic incisions was required in 56 cases (2.2%). Perioperative rates of revision for bleeding, stroke, and mortality were 56 (2.2%), 6 (0.2 %), and 27 (1.1%), respectively. Median postoperative hospital length of stay was 6.6 (6.6) days. Conclusion: Robotic cardiac surgery case numbers in Europe are growing fast, including a large spectrum of procedures. Conversion rates are low and clinical outcomes are favorable, indicating safe conduct of these high-tech minimally invasive procedures.
Acibadem Maslak Hospital Acibadem University Istanbul Turkey
AZ Maria Middelares Ghent Belgium
CHU UCL Namur Site Godinne Namur Belgium
Cliniques Univesitaires Saint Luc Brussels Belgium
Department of Cardiovascular Sciences University Hospital Leuven KU Leuven Leuven Belgium
Erasme Hospital Brussels Brussels Belgium
Gulhane Education ve Research Hospital Ankara Turkey
Henri MONDOR Hospital Assitance Publique Hopitaux de Paris Paris France
Hospital Clínic de Barcelona Barcelona Spain
Humanita Gavazzeni Bergamo Italy
Imelda Hospital Bonheiden Bonheiden Belgium
ISALA Hospital Zwolle Netherlands
Leiden University Medical Center Leiden Netherlands
Liverpool Heart and Chest Liverpool United Kingdom
Maastricht University Medical Center Maastricht Netherlands
MONZA Hospital Bucharest Romania
Na Homolce Hospital Prague Czechia
Robert Bosch Hospital Stuttgart Germany
Rouen University Hospital Rouen France
San Camillo Hospital Rome Italy
University Hospital Bordeaux Bordeaux France
University Hospital Ghent Ghent Belgium
University Hospital Hradec Kralove Hradec Kralove Czechia
University Hospital Zurich Zurich Switzerland
University Medical Centre Utrecht Utrecht Netherlands
University of Pittsburgh Medical Center Pittsburgh PA United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010194
- 003
- CZ-PrNML
- 005
- 20220425131744.0
- 007
- ta
- 008
- 220420s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fcvm.2021.827515 $2 doi
- 035 __
- $a (PubMed)35127877
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Cerny, Stepan $u Na Homolce Hospital, Prague, Czechia
- 245 10
- $a Robotic Cardiac Surgery in Europe: Status 2020 / $c S. Cerny, W. Oosterlinck, B. Onan, S. Singh, P. Segers, C. Bolcal, C. Alhan, E. Navarra, M. Pettinari, F. Van Praet, H. De Praetere, J. Vojacek, T. Cebotaru, P. Modi, F. Doguet, U. Franke, A. Ouda, L. Melly, G. Malapert, L. Labrousse, M. Gianoli, A. Agnino, T. Philipsen, JL. Jansens, T. Folliguet, M. Palmen, D. Pereda, F. Musumeci, P. Suwalski, K. Cathenis, J. Van den Eynde, J. Bonatti
- 520 9_
- $a Background: European surgeons were the first worldwide to use robotic techniques in cardiac surgery and major steps in procedure development were taken in Europe. After a hype in the early 2000s case numbers decreased but due to technological improvements renewed interest can be noted. We assessed the current activities and outcomes in robotically assisted cardiac surgery on the European continent. Methods: Data were collected in an international anonymized registry of 26 European centers with a robotic cardiac surgery program. Results: During a 4-year period (2016-2019), 2,563 procedures were carried out [30.0% female, 58.5 (15.4) years old, EuroSCORE II 1.56 (1.74)], including robotically assisted coronary bypass grafting (n = 1266, 49.4%), robotic mitral or tricuspid valve surgery (n = 945, 36.9%), isolated atrial septal defect closure (n = 225, 8.8%), left atrial myxoma resection (n = 54, 2.1%), and other procedures (n = 73, 2.8%). The number of procedures doubled during the study period (from n = 435 in 2016 to n = 923 in 2019). The mean cardiopulmonary bypass time in pump assisted cases was 148.6 (63.5) min and the myocardial ischemic time was 88.7 (46.1) min. Conversion to larger thoracic incisions was required in 56 cases (2.2%). Perioperative rates of revision for bleeding, stroke, and mortality were 56 (2.2%), 6 (0.2 %), and 27 (1.1%), respectively. Median postoperative hospital length of stay was 6.6 (6.6) days. Conclusion: Robotic cardiac surgery case numbers in Europe are growing fast, including a large spectrum of procedures. Conversion rates are low and clinical outcomes are favorable, indicating safe conduct of these high-tech minimally invasive procedures.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Oosterlinck, Wouter $u Department of Cardiovascular Sciences, University Hospital Leuven, KU Leuven, Leuven, Belgium
- 700 1_
- $a Onan, Burak $u Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Hospital, University of Health Sciences, Istanbul, Turkey
- 700 1_
- $a Singh, Sandeep $u ISALA Hospital, Zwolle, Netherlands
- 700 1_
- $a Segers, Patrique $u Maastricht University Medical Center, Maastricht, Netherlands
- 700 1_
- $a Bolcal, Cengiz $u Gulhane Education ve Research Hospital, Ankara, Turkey
- 700 1_
- $a Alhan, Cem $u Acibadem Maslak Hospital, Acibadem University, Istanbul, Turkey
- 700 1_
- $a Navarra, Emiliano $u Cliniques Univesitaires Saint Luc, Brussels, Belgium
- 700 1_
- $a Pettinari, Matteo $u Ziekenhuis Oost Limburg, Genk, Belgium
- 700 1_
- $a Van Praet, Frank $u OLV Ziekenhuis, Aalst, Belgium
- 700 1_
- $a De Praetere, Herbert $u Imelda Hospital Bonheiden, Bonheiden, Belgium
- 700 1_
- $a Vojacek, Jan $u University Hospital Hradec Kralove, Hradec Kralove, Czechia
- 700 1_
- $a Cebotaru, Theodor $u MONZA Hospital, Bucharest, Romania
- 700 1_
- $a Modi, Paul $u Liverpool Heart and Chest, Liverpool, United Kingdom
- 700 1_
- $a Doguet, Fabien $u Rouen University Hospital, Rouen, France
- 700 1_
- $a Franke, Ulrich $u Robert Bosch Hospital, Stuttgart, Germany
- 700 1_
- $a Ouda, Ahmed $u University Hospital Zurich, Zurich, Switzerland
- 700 1_
- $a Melly, Ludovic $u CHU UCL Namur - Site Godinne, Namur, Belgium
- 700 1_
- $a Malapert, Ghislain $u CHU Dijon, Dijon, France
- 700 1_
- $a Labrousse, Louis $u University Hospital Bordeaux, Bordeaux, France
- 700 1_
- $a Gianoli, Monica $u University Medical Centre Utrecht, Utrecht, Netherlands
- 700 1_
- $a Agnino, Alfonso $u Humanita Gavazzeni, Bergamo, Italy
- 700 1_
- $a Philipsen, Tine $u University Hospital Ghent, Ghent, Belgium
- 700 1_
- $a Jansens, Jean-Luc $u Erasme Hospital Brussels, Brussels, Belgium
- 700 1_
- $a Folliguet, Thierry $u Henri MONDOR Hospital, Assitance Publique/Hopitaux de Paris, Paris, France
- 700 1_
- $a Palmen, Meindert $u Leiden University Medical Center, Leiden, Netherlands
- 700 1_
- $a Pereda, Daniel $u Hospital Clínic de Barcelona, Barcelona, Spain
- 700 1_
- $a Musumeci, Francesco $u San Camillo Hospital, Rome, Italy
- 700 1_
- $a Suwalski, Piotr $u Central Teaching Hospital of the Ministry of the Interior and Administration, Centre of Postgraduate Medical Education, Warsaw, Poland
- 700 1_
- $a Cathenis, Koen $u AZ Maria Middelares, Ghent, Belgium
- 700 1_
- $a Van den Eynde, Jef $u Department of Cardiovascular Sciences, University Hospital Leuven, KU Leuven, Leuven, Belgium
- 700 1_
- $a Bonatti, Johannes $u University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, United States
- 773 0_
- $w MED00198704 $t Frontiers in cardiovascular medicine $x 2297-055X $g Roč. 8, č. - (2021), s. 827515
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35127877 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220420 $b ABA008
- 991 __
- $a 20220425131742 $b ABA008
- 999 __
- $a ind $b bmc $g 1784523 $s 1161392
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 8 $c - $d 827515 $e 20220120 $i 2297-055X $m Frontiers in cardiovascular medicine $n Front Cardiovasc Med $x MED00198704
- LZP __
- $a Pubmed-20220420
